Paul H. Ratner

Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective

Charles E. Lamb, Paul H. Ratner, Clarion E. Johnson et al. · Current Medical Research and Opinion · 2006 · 292 citations

Public Health, Human Resource Management, Allergy +16

Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the spring

George Philip, K. Malmström, Frank C. Hampel et al. · Clinical & Experimental Allergy · 2002 · 242 citations

Life Sciences, Pharmacology, Pharmacotherapy +16

Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device

Frank C. Hampel, Paul H. Ratner, Julius van Bavel et al. · Annals of Allergy Asthma & Immunology · 2010 · 152 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis

Paul H. Ratner, Frank C. Hampel, Julius van Bavel et al. · Annals of Allergy Asthma & Immunology · 2008 · 131 citations

Pharmacy, Pharmacotherapy, Allergy +16

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

Janet van Adelsberg, George Philip, A. Pedinoff et al. · Allergy · 2003 · 126 citations

Pharmacy, Pharmacology, Pharmacotherapy +17